Literature DB >> 2890915

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation.

D Ullrich, D Rating, W Schröter, F Hanefeld, J Bircher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2890915     DOI： 10.1016/s0140-6736(87)91208-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  New directions in primary biliary cirrhosis.

Authors:  M C Bateson
Journal:  BMJ       Date:  1990-12-08

Review 2.  Use of ursodeoxycholic acid in patients with liver disease.

Authors:  Paul Angulo
Journal:  Curr Gastroenterol Rep       Date:  2002-02

3.  Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.

Authors:  J Cotting; M J Lentze; J Reichen
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 4.  [Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?].

Authors:  J Pausch; M Gatzen
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

Review 5.  Ursodeoxycholic acid in chronic liver disease.

Authors:  J S de Caestecker; R P Jazrawi; M L Petroni; T C Northfield
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 6.  A Current Understanding of Bile Acids in Chronic Liver Disease.

Authors:  Naba Farooqui; Anshuman Elhence
Journal:  J Clin Exp Hepatol       Date:  2021-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.